Medico Remedies Limited (MEDICO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medico Remedies Limited (MEDICO) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs6.43 Million ≈ $69.54K USD) by net assets (Rs668.58 Million ≈ $7.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MEDICO days of operational coverage to measure how many days the company can operate on defensive assets alone.
Medico Remedies Limited - Cash Flow Conversion Efficiency Trend (2013–2026)
This chart illustrates how Medico Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medico Remedies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medico Remedies Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Blackboxstocks Inc
NASDAQ:BLBX
|
-0.090x |
|
Sepeda Bersama Indonesia Tbk PT
JK:BIKE
|
-0.079x |
|
Hojeon Ltd
KO:111110
|
0.074x |
|
Toplus Global Co Ltd
TWO:3522
|
0.184x |
|
INFOMARK Co. Ltd
KQ:175140
|
0.067x |
|
Anteotech Ltd
AU:ADO
|
-0.264x |
|
CESSATECH A/S DK -20
F:8GN
|
-0.025x |
|
First Graphene Ltd
AU:FGR
|
-0.095x |
Annual Cash Flow Conversion Efficiency for Medico Remedies Limited (2013–2026)
The table below shows the annual cash flow conversion efficiency of Medico Remedies Limited from 2013 to 2026. For the full company profile with market capitalisation and key ratios, see how much is Medico Remedies Limited worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs754.74 Million ≈ $8.16 Million |
Rs10.06 Million ≈ $108.82K |
0.013x | -82.98% |
| 2025-03-31 | Rs624.69 Million ≈ $6.76 Million |
Rs48.92 Million ≈ $529.06K |
0.078x | +68.23% |
| 2024-03-31 | Rs523.71 Million ≈ $5.66 Million |
Rs24.38 Million ≈ $263.65K |
0.047x | -75.01% |
| 2023-03-31 | Rs438.43 Million ≈ $4.74 Million |
Rs81.67 Million ≈ $883.25K |
0.186x | +18.60% |
| 2022-03-31 | Rs373.20 Million ≈ $4.04 Million |
Rs58.62 Million ≈ $633.95K |
0.157x | +145.08% |
| 2021-03-31 | Rs324.58 Million ≈ $3.51 Million |
Rs-113.10 Million ≈ $-1.22 Million |
-0.348x | -1175.78% |
| 2020-03-31 | Rs298.66 Million ≈ $3.23 Million |
Rs9.67 Million ≈ $104.62K |
0.032x | -81.43% |
| 2019-03-31 | Rs282.36 Million ≈ $3.05 Million |
Rs49.24 Million ≈ $532.54K |
0.174x | -8.75% |
| 2018-03-31 | Rs266.66 Million ≈ $2.88 Million |
Rs50.97 Million ≈ $551.17K |
0.191x | +202.51% |
| 2017-03-31 | Rs163.72 Million ≈ $1.77 Million |
Rs-30.52 Million ≈ $-330.12K |
-0.186x | +26.28% |
| 2016-03-31 | Rs147.44 Million ≈ $1.59 Million |
Rs-37.29 Million ≈ $-403.27K |
-0.253x | -980.71% |
| 2015-03-31 | Rs136.14 Million ≈ $1.47 Million |
Rs-3.19 Million ≈ $-34.46K |
-0.023x | -107.36% |
| 2014-03-31 | Rs85.72 Million ≈ $927.00K |
Rs27.27 Million ≈ $294.96K |
0.318x | -21.78% |
| 2013-03-31 | Rs50.55 Million ≈ $546.71K |
Rs20.57 Million ≈ $222.40K |
0.407x | -- |
About Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more